This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christensen, H. S.
Right arrow Articles by Gatignol, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christensen, H. S.
Right arrow Articles by Gatignol, A.

 Previous Article  |  Next Article 

Journal of Virology, May 2007, p. 5121-5131, Vol. 81, No. 10
0022-538X/07/$08.00+0     doi:10.1128/JVI.01511-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Small Interfering RNAs against the TAR RNA Binding Protein, TRBP, a Dicer Cofactor, Inhibit Human Immunodeficiency Virus Type 1 Long Terminal Repeat Expression and Viral Production{triangledown}

Helen S. Christensen,1 Aïcha Daher,2 Kaitlin J. Soye,2,3 Lisa B. Frankel,2,3,{dagger} Marina R. Alexander,1 Sébastien Lainé,2,3 Sylvie Bannwarth,2,3,{ddagger} Chi L. Ong,1 Sean W. L. Chung,1 Shahan M. Campbell,1 Damian F. J. Purcell,1,§* and Anne Gatignol2,3,4,§*

Department of Microbiology and Immunology, University of Melbourne, Parkville, Australia,1 Virus-Cell Interactions Laboratory, Lady Davis Institute for Medical Research,2 Departments of Microbiology and Immunology,3 Experimental Medicine, McGill University, Montréal, Québec, Canada4

Received 14 July 2006/ Accepted 25 February 2007

RNA interference (RNAi) is now widely used for gene silencing in mammalian cells. The mechanism uses the RNA-induced silencing complex, in which Dicer, Ago2, and the human immunodeficiency virus type 1 (HIV-1) TAR RNA binding protein (TRBP) are the main components. TRBP is a protein that increases HIV-1 expression and replication by inhibition of the interferon-induced protein kinase PKR and by increasing translation of viral mRNA. After HIV infection, TRBP could restrict the viral RNA through its activity in RNAi or could contribute more to the enhancement of viral replication. To determine which function will be predominant in the virological context, we analyzed whether the inhibition of its expression could enhance or decrease HIV replication. We have generated small interfering RNAs (siRNAs) against TRBP and found that they decrease HIV-1 long terminal repeat (LTR) basal expression 2-fold, and the LTR Tat transactivated level up to 10-fold. In the context of HIV replication, siRNAs against TRBP decrease the expression of viral genes and inhibit viral production up to fivefold. The moderate increase in PKR expression and activation indicates that it contributes partially to viral gene inhibition. The moderate decrease in micro-RNA (miRNA) biogenesis by TRBP siRNAs suggests that in the context of HIV replication, TRBP functions other than RNAi are predominant. In addition, siRNAs against Dicer decrease viral production twofold and impede miRNA biogenesis. These results suggest that, in the context of HIV replication, TRBP contributes mainly to the enhancement of virus production and that Dicer does not mediate HIV restriction by RNAi.

* Corresponding author. Mailing address for Anne Gatignol: Virus-Cell Interactions Laboratory, Lady Davis Institute for Medical Research, 3755 Côte Ste Catherine, Montréal QC H3T 1E2, Canada. Phone: (514) 340-8260, ext. 5284. Fax: (514) 340-7576. E-mail: anne.gatignol{at}mcgill.ca. Mailing address for Damian F. J. Purcell: Department of Microbiology and Immunology, The University of Melbourne, Parkville 3010, Victoria, Australia. Phone: 61 3 8344 6753. Fax: 61 3 9347 1540. E-mail: dfjp{at}unimelb.edu.au

{triangledown} Published ahead of print on 14 March 2007.

{dagger} Present address: Biotech Research and Innovation Center, University of Copenhagen, Copenhagen, Denmark.

{ddagger} Present address: Laboratoire de Génétique Moléculaire, Hôpital de l'Archet 2, Nice, France.

§ The laboratories of A.G. and D.F.J.P. contributed equally to this work.

Journal of Virology, May 2007, p. 5121-5131, Vol. 81, No. 10
0022-538X/07/$08.00+0     doi:10.1128/JVI.01511-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Clerzius, G., Gelinas, J.-F., Daher, A., Bonnet, M., Meurs, E. F., Gatignol, A. (2009). ADAR1 Interacts with PKR during Human Immunodeficiency Virus Infection of Lymphocytes and Contributes to Viral Replication. J. Virol. 83: 10119-10128 [Abstract] [Full Text]  
  • Keating, C. P., Hill, M. K., Hawkes, D. J., Smyth, R. P., Isel, C., Le, S.-Y., Palmenberg, A. C., Marshall, J. A., Marquet, R., Nabel, G. J., Mak, J. (2009). The A-rich RNA sequences of HIV-1 pol are important for the synthesis of viral cDNA. Nucleic Acids Res 37: 945-956 [Abstract] [Full Text]  
  • Daher, A., Laraki, G., Singh, M., Melendez-Pena, C. E., Bannwarth, S., Peters, A. H. F. M., Meurs, E. F., Braun, R. E., Patel, R. C., Gatignol, A. (2009). TRBP Control of PACT-Induced Phosphorylation of Protein Kinase R Is Reversed by Stress. Mol. Cell. Biol. 29: 254-265 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»